The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Infectious Coryza Vaccine Market Research Report 2024
Synopsis
Infectious Coryza Vaccine is used to prevent infectious rhinitis in chickens caused by Avian bacillus paragallinarum. The method is subcutaneous injection on the back of the neck.
The global Infectious Coryza Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Coryza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Coryza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Coryza Vaccine include Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd. and Qingdao Yibang Biological Engineering Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Coryza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Coryza Vaccine.
Report Scope
The Infectious Coryza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Coryza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Coryza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Boehringer Ingelheim
Ceva Santé Animale
Qilu Animal Health Products Co., Ltd.
Tianjin Ruipu Biotechnology Co., Ltd.
Harbin Pharmaceutical Group
Plyco Bioengineering Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Huahong Biological Engineering Co., Ltd.
Segment by Type
Monovalent Vaccine
Bivalent Vaccine
Trivalent Vaccine
Segment by Application
Retail
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Coryza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Coryza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Infectious Coryza Vaccine is used to prevent infectious rhinitis in chickens caused by Avian bacillus paragallinarum. The method is subcutaneous injection on the back of the neck.
The global Infectious Coryza Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Infectious Coryza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Infectious Coryza Vaccine is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Infectious Coryza Vaccine include Zoetis, Merck, Boehringer Ingelheim, Ceva Santé Animale, Qilu Animal Health Products Co., Ltd., Tianjin Ruipu Biotechnology Co., Ltd., Harbin Pharmaceutical Group, Plyco Bioengineering Co., Ltd. and Qingdao Yibang Biological Engineering Co., Ltd., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Infectious Coryza Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Infectious Coryza Vaccine.
Report Scope
The Infectious Coryza Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Infectious Coryza Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Infectious Coryza Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Zoetis
Merck
Boehringer Ingelheim
Ceva Santé Animale
Qilu Animal Health Products Co., Ltd.
Tianjin Ruipu Biotechnology Co., Ltd.
Harbin Pharmaceutical Group
Plyco Bioengineering Co., Ltd.
Qingdao Yibang Biological Engineering Co., Ltd.
Shandong Lvdu Biological Technology Co., Ltd.
Shandong Huahong Biological Engineering Co., Ltd.
Segment by Type
Monovalent Vaccine
Bivalent Vaccine
Trivalent Vaccine
Segment by Application
Retail
Online Sale
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Infectious Coryza Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Infectious Coryza Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Infectious Coryza Vaccine Market Overview
1.1 Product Overview and Scope of Infectious Coryza Vaccine
1.2 Infectious Coryza Vaccine Segment by Type
1.2.1 Global Infectious Coryza Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 Monovalent Vaccine
1.2.3 Bivalent Vaccine
1.2.4 Trivalent Vaccine
1.3 Infectious Coryza Vaccine Segment by Application
1.3.1 Global Infectious Coryza Vaccine Market Value by Application: (2024-2030)
1.3.2 Retail
1.3.3 Online Sale
1.3.4 Others
1.4 Global Infectious Coryza Vaccine Market Size Estimates and Forecasts
1.4.1 Global Infectious Coryza Vaccine Revenue 2019-2030
1.4.2 Global Infectious Coryza Vaccine Sales 2019-2030
1.4.3 Global Infectious Coryza Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Infectious Coryza Vaccine Market Competition by Manufacturers
2.1 Global Infectious Coryza Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Infectious Coryza Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Infectious Coryza Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Infectious Coryza Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Infectious Coryza Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Infectious Coryza Vaccine, Product Type & Application
2.7 Infectious Coryza Vaccine Market Competitive Situation and Trends
2.7.1 Infectious Coryza Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Infectious Coryza Vaccine Players Market Share by Revenue
2.7.3 Global Infectious Coryza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Infectious Coryza Vaccine Retrospective Market Scenario by Region
3.1 Global Infectious Coryza Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Infectious Coryza Vaccine Global Infectious Coryza Vaccine Sales by Region: 2019-2030
3.2.1 Global Infectious Coryza Vaccine Sales by Region: 2019-2024
3.2.2 Global Infectious Coryza Vaccine Sales by Region: 2025-2030
3.3 Global Infectious Coryza Vaccine Global Infectious Coryza Vaccine Revenue by Region: 2019-2030
3.3.1 Global Infectious Coryza Vaccine Revenue by Region: 2019-2024
3.3.2 Global Infectious Coryza Vaccine Revenue by Region: 2025-2030
3.4 North America Infectious Coryza Vaccine Market Facts & Figures by Country
3.4.1 North America Infectious Coryza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Infectious Coryza Vaccine Sales by Country (2019-2030)
3.4.3 North America Infectious Coryza Vaccine Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Infectious Coryza Vaccine Market Facts & Figures by Country
3.5.1 Europe Infectious Coryza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Infectious Coryza Vaccine Sales by Country (2019-2030)
3.5.3 Europe Infectious Coryza Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Infectious Coryza Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Infectious Coryza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Infectious Coryza Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Infectious Coryza Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Infectious Coryza Vaccine Market Facts & Figures by Country
3.7.1 Latin America Infectious Coryza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Infectious Coryza Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Infectious Coryza Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Infectious Coryza Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Infectious Coryza Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Infectious Coryza Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Infectious Coryza Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Infectious Coryza Vaccine Sales by Type (2019-2030)
4.1.1 Global Infectious Coryza Vaccine Sales by Type (2019-2024)
4.1.2 Global Infectious Coryza Vaccine Sales by Type (2025-2030)
4.1.3 Global Infectious Coryza Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Infectious Coryza Vaccine Revenue by Type (2019-2030)
4.2.1 Global Infectious Coryza Vaccine Revenue by Type (2019-2024)
4.2.2 Global Infectious Coryza Vaccine Revenue by Type (2025-2030)
4.2.3 Global Infectious Coryza Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Infectious Coryza Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Infectious Coryza Vaccine Sales by Application (2019-2030)
5.1.1 Global Infectious Coryza Vaccine Sales by Application (2019-2024)
5.1.2 Global Infectious Coryza Vaccine Sales by Application (2025-2030)
5.1.3 Global Infectious Coryza Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Infectious Coryza Vaccine Revenue by Application (2019-2030)
5.2.1 Global Infectious Coryza Vaccine Revenue by Application (2019-2024)
5.2.2 Global Infectious Coryza Vaccine Revenue by Application (2025-2030)
5.2.3 Global Infectious Coryza Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Infectious Coryza Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Zoetis
6.1.1 Zoetis Corporation Information
6.1.2 Zoetis Description and Business Overview
6.1.3 Zoetis Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Zoetis Infectious Coryza Vaccine Product Portfolio
6.1.5 Zoetis Recent Developments/Updates
6.2 Merck
6.2.1 Merck Corporation Information
6.2.2 Merck Description and Business Overview
6.2.3 Merck Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Merck Infectious Coryza Vaccine Product Portfolio
6.2.5 Merck Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Boehringer Ingelheim Infectious Coryza Vaccine Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Ceva Santé Animale
6.4.1 Ceva Santé Animale Corporation Information
6.4.2 Ceva Santé Animale Description and Business Overview
6.4.3 Ceva Santé Animale Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Ceva Santé Animale Infectious Coryza Vaccine Product Portfolio
6.4.5 Ceva Santé Animale Recent Developments/Updates
6.5 Qilu Animal Health Products Co., Ltd.
6.5.1 Qilu Animal Health Products Co., Ltd. Corporation Information
6.5.2 Qilu Animal Health Products Co., Ltd. Description and Business Overview
6.5.3 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.5.5 Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
6.6 Tianjin Ruipu Biotechnology Co., Ltd.
6.6.1 Tianjin Ruipu Biotechnology Co., Ltd. Corporation Information
6.6.2 Tianjin Ruipu Biotechnology Co., Ltd. Description and Business Overview
6.6.3 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.6.5 Tianjin Ruipu Biotechnology Co., Ltd. Recent Developments/Updates
6.7 Harbin Pharmaceutical Group
6.6.1 Harbin Pharmaceutical Group Corporation Information
6.6.2 Harbin Pharmaceutical Group Description and Business Overview
6.6.3 Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Harbin Pharmaceutical Group Infectious Coryza Vaccine Product Portfolio
6.7.5 Harbin Pharmaceutical Group Recent Developments/Updates
6.8 Plyco Bioengineering Co., Ltd.
6.8.1 Plyco Bioengineering Co., Ltd. Corporation Information
6.8.2 Plyco Bioengineering Co., Ltd. Description and Business Overview
6.8.3 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.8.5 Plyco Bioengineering Co., Ltd. Recent Developments/Updates
6.9 Qingdao Yibang Biological Engineering Co., Ltd.
6.9.1 Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
6.9.2 Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
6.9.3 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.9.5 Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
6.10 Shandong Lvdu Biological Technology Co., Ltd.
6.10.1 Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
6.10.2 Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
6.10.3 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.10.5 Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
6.11 Shandong Huahong Biological Engineering Co., Ltd.
6.11.1 Shandong Huahong Biological Engineering Co., Ltd. Corporation Information
6.11.2 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Description and Business Overview
6.11.3 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product Portfolio
6.11.5 Shandong Huahong Biological Engineering Co., Ltd. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Infectious Coryza Vaccine Industry Chain Analysis
7.2 Infectious Coryza Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Infectious Coryza Vaccine Production Mode & Process
7.4 Infectious Coryza Vaccine Sales and Marketing
7.4.1 Infectious Coryza Vaccine Sales Channels
7.4.2 Infectious Coryza Vaccine Distributors
7.5 Infectious Coryza Vaccine Customers
8 Infectious Coryza Vaccine Market Dynamics
8.1 Infectious Coryza Vaccine Industry Trends
8.2 Infectious Coryza Vaccine Market Drivers
8.3 Infectious Coryza Vaccine Market Challenges
8.4 Infectious Coryza Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Infectious Coryza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Infectious Coryza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Infectious Coryza Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Infectious Coryza Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Infectious Coryza Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Infectious Coryza Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Infectious Coryza Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Infectious Coryza Vaccine Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Infectious Coryza Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Infectious Coryza Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Infectious Coryza Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Infectious Coryza Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Infectious Coryza Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infectious Coryza Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Infectious Coryza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Infectious Coryza Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Infectious Coryza Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Infectious Coryza Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Infectious Coryza Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Infectious Coryza Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Infectious Coryza Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Infectious Coryza Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Infectious Coryza Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Infectious Coryza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Infectious Coryza Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Infectious Coryza Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Infectious Coryza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Infectious Coryza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Infectious Coryza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Infectious Coryza Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Infectious Coryza Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Infectious Coryza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Infectious Coryza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Infectious Coryza Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Infectious Coryza Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Infectious Coryza Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Infectious Coryza Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Infectious Coryza Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Infectious Coryza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Infectious Coryza Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Infectious Coryza Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Infectious Coryza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Infectious Coryza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Infectious Coryza Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Infectious Coryza Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Infectious Coryza Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Infectious Coryza Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Infectious Coryza Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Infectious Coryza Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Infectious Coryza Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Infectious Coryza Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Infectious Coryza Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Infectious Coryza Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Infectious Coryza Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Infectious Coryza Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Infectious Coryza Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2019-2024)
Table 59. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2025-2030)
Table 60. Global Infectious Coryza Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Infectious Coryza Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Infectious Coryza Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Infectious Coryza Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Infectious Coryza Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Infectious Coryza Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Infectious Coryza Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Infectious Coryza Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2019-2024)
Table 69. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2025-2030)
Table 70. Zoetis Corporation Information
Table 71. Zoetis Description and Business Overview
Table 72. Zoetis Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Zoetis Infectious Coryza Vaccine Product
Table 74. Zoetis Recent Developments/Updates
Table 75. Merck Corporation Information
Table 76. Merck Description and Business Overview
Table 77. Merck Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Merck Infectious Coryza Vaccine Product
Table 79. Merck Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Boehringer Ingelheim Infectious Coryza Vaccine Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Ceva Santé Animale Corporation Information
Table 86. Ceva Santé Animale Description and Business Overview
Table 87. Ceva Santé Animale Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Ceva Santé Animale Infectious Coryza Vaccine Product
Table 89. Ceva Santé Animale Recent Developments/Updates
Table 90. Qilu Animal Health Products Co., Ltd. Corporation Information
Table 91. Qilu Animal Health Products Co., Ltd. Description and Business Overview
Table 92. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. Qilu Animal Health Products Co., Ltd. Infectious Coryza Vaccine Product
Table 94. Qilu Animal Health Products Co., Ltd. Recent Developments/Updates
Table 95. Tianjin Ruipu Biotechnology Co., Ltd. Corporation Information
Table 96. Tianjin Ruipu Biotechnology Co., Ltd. Description and Business Overview
Table 97. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. Tianjin Ruipu Biotechnology Co., Ltd. Infectious Coryza Vaccine Product
Table 99. Tianjin Ruipu Biotechnology Co., Ltd. Recent Developments/Updates
Table 100. Harbin Pharmaceutical Group Corporation Information
Table 101. Harbin Pharmaceutical Group Description and Business Overview
Table 102. Harbin Pharmaceutical Group Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Harbin Pharmaceutical Group Infectious Coryza Vaccine Product
Table 104. Harbin Pharmaceutical Group Recent Developments/Updates
Table 105. Plyco Bioengineering Co., Ltd. Corporation Information
Table 106. Plyco Bioengineering Co., Ltd. Description and Business Overview
Table 107. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Plyco Bioengineering Co., Ltd. Infectious Coryza Vaccine Product
Table 109. Plyco Bioengineering Co., Ltd. Recent Developments/Updates
Table 110. Qingdao Yibang Biological Engineering Co., Ltd. Corporation Information
Table 111. Qingdao Yibang Biological Engineering Co., Ltd. Description and Business Overview
Table 112. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Qingdao Yibang Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product
Table 114. Qingdao Yibang Biological Engineering Co., Ltd. Recent Developments/Updates
Table 115. Shandong Lvdu Biological Technology Co., Ltd. Corporation Information
Table 116. Shandong Lvdu Biological Technology Co., Ltd. Description and Business Overview
Table 117. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Shandong Lvdu Biological Technology Co., Ltd. Infectious Coryza Vaccine Product
Table 119. Shandong Lvdu Biological Technology Co., Ltd. Recent Developments/Updates
Table 120. Shandong Huahong Biological Engineering Co., Ltd. Corporation Information
Table 121. Shandong Huahong Biological Engineering Co., Ltd. Description and Business Overview
Table 122. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Shandong Huahong Biological Engineering Co., Ltd. Infectious Coryza Vaccine Product
Table 124. Shandong Huahong Biological Engineering Co., Ltd. Recent Developments/Updates
Table 125. Key Raw Materials Lists
Table 126. Raw Materials Key Suppliers Lists
Table 127. Infectious Coryza Vaccine Distributors List
Table 128. Infectious Coryza Vaccine Customers List
Table 129. Infectious Coryza Vaccine Market Trends
Table 130. Infectious Coryza Vaccine Market Drivers
Table 131. Infectious Coryza Vaccine Market Challenges
Table 132. Infectious Coryza Vaccine Market Restraints
Table 133. Research Programs/Design for This Report
Table 134. Key Data Information from Secondary Sources
Table 135. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Infectious Coryza Vaccine
Figure 2. Global Infectious Coryza Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Infectious Coryza Vaccine Market Share by Type in 2023 & 2030
Figure 4. Monovalent Vaccine Product Picture
Figure 5. Bivalent Vaccine Product Picture
Figure 6. Trivalent Vaccine Product Picture
Figure 7. Global Infectious Coryza Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Infectious Coryza Vaccine Market Share by Application in 2023 & 2030
Figure 9. Retail
Figure 10. Online Sale
Figure 11. Others
Figure 12. Global Infectious Coryza Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Infectious Coryza Vaccine Market Size (2019-2030) & (US$ Million)
Figure 14. Global Infectious Coryza Vaccine Sales (2019-2030) & (K Units)
Figure 15. Global Infectious Coryza Vaccine Average Price (US$/Unit) & (2019-2030)
Figure 16. Infectious Coryza Vaccine Report Years Considered
Figure 17. Infectious Coryza Vaccine Sales Share by Manufacturers in 2023
Figure 18. Global Infectious Coryza Vaccine Revenue Share by Manufacturers in 2023
Figure 19. The Global 5 and 10 Largest Infectious Coryza Vaccine Players: Market Share by Revenue in 2023
Figure 20. Infectious Coryza Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 21. Global Infectious Coryza Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 22. North America Infectious Coryza Vaccine Sales Market Share by Country (2019-2030)
Figure 23. North America Infectious Coryza Vaccine Revenue Market Share by Country (2019-2030)
Figure 24. United States Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Canada Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 26. Europe Infectious Coryza Vaccine Sales Market Share by Country (2019-2030)
Figure 27. Europe Infectious Coryza Vaccine Revenue Market Share by Country (2019-2030)
Figure 28. Germany Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. France Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. U.K. Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Italy Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Russia Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Asia Pacific Infectious Coryza Vaccine Sales Market Share by Region (2019-2030)
Figure 34. Asia Pacific Infectious Coryza Vaccine Revenue Market Share by Region (2019-2030)
Figure 35. China Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. Japan Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. South Korea Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. India Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Australia Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. China Taiwan Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Indonesia Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Thailand Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Malaysia Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Infectious Coryza Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Infectious Coryza Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Infectious Coryza Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Infectious Coryza Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Infectious Coryza Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Infectious Coryza Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Infectious Coryza Vaccine by Type (2019-2030)
Figure 56. Global Infectious Coryza Vaccine Price (US$/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Infectious Coryza Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Infectious Coryza Vaccine by Application (2019-2030)
Figure 59. Global Infectious Coryza Vaccine Price (US$/Unit) by Application (2019-2030)
Figure 60. Infectious Coryza Vaccine Value Chain
Figure 61. Infectious Coryza Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
